Skip to content
value.today

Taris Biomedical Inc.

🇺🇸 Waltham, Massachusetts, USABiotechnologyFounded 2008
Total raised
$37 M
3 rounds on record
Latest round
$14 M
Mar 2013
First round on record
Dec 2009
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Taris Biomedical Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2013$14 MNo. 3$10 to $50 million

Taris Biomedical Inc.: Raise no. 3, Mar 2013

Investors in this round

11 investors had bought by the notice of Apr 2, 2013: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Diane Marcou · Executive Officer
  • Purnanand Sarma · Executive Officer, Director
  • Cary Pfeffer · Director
  • Dennis Ausiello · Director
  • Edward Kania · Director
  • Kevin Bitterman · Director
  • Michael Cima · Director
  • Michael Greeley · Director
  • Robert Langer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Purnanand Sarma, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 2, 2013. Read the notice at the SEC.

equitySEC
Apr 2011$18 MNo. 2$10 to $50 million

Taris Biomedical Inc.: Raise no. 2, Apr 2011

Investors in this round

8 investors had bought by the notice of Apr 4, 2013: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$18 M of $19 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Diane Marcou · Executive Officer
  • Sarma Duddy · Executive Officer, Director
  • Dennis Ausiello · Director
  • Edward Kania · Director
  • Ernie Mario · Director
  • Kevin Bitterman · Director
  • Michael Cima · Director
  • Michael Greeley · Director
  • Robert Langer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “This amendment is being filed to withdraw the Form D amendment filed on April 2, 2013 which was inadvertently submitted.”
  • On the use of proceeds: “This amendment is being filed to withdraw the Form D amendment filed on April 2, 2013 which was inadvertently submitted.”

Signed by Sarma Duddy, President and Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Apr 4, 2013. Read the notice at the SEC.

equitySEC
Dec 2009$5 MNo. 1$2 to $10 million

Taris Biomedical Inc.: Raise no. 1, Dec 2009

Investors in this round

7 investors had bought by the notice of Dec 16, 2009: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christine Bunt · Executive Officer, Director
  • Michael Cima · Executive Officer, Director
  • Robert Crane · Executive Officer
  • Dennis Ausiello · Director
  • Ed Kania · Director
  • Ernie Mario · Director
  • Kevin Bitterman · Director
  • Michael Greeley · Director
  • Robert Langer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert Crane, Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 16, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Taris Biomedical Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2013).

    SEC Form D · Apr 2013

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2013

That is all the official record says: Taris Biomedical Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Taris Biomedical Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 11 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Taris Biomedical Inc.
NameRoleNamed in
Diane MarcouExecutive officerApr 2013
Sarma DuddyExecutive officerApr 2013
Purnanand SarmaExecutive officerApr 2013
Christine BuntExecutive officerDec 2009
Michael CimaExecutive officerDec 2009
Robert CraneExecutive officerDec 2009
Dennis AusielloDirectorApr 2013
Edward KaniaDirectorApr 2013
Ernie MarioDirectorApr 2013
Kevin BittermanDirectorApr 2013
Michael CimaDirectorApr 2013
Michael GreeleyDirectorApr 2013
Robert LangerDirectorApr 2013
Sarma DuddyDirectorApr 2013
Cary PfefferDirectorApr 2013
Purnanand SarmaDirectorApr 2013
Ed KaniaDirectorApr 2011
Christine BuntDirectorDec 2009